Our Licensing & Deal Strategy service helps pharmaceutical and biotech companies identify, evaluate, and execute licensing opportunities. We combine AI-powered asset identification with deep commercial valuation expertise to surface the highest-value deals. From target screening to term sheet development, we support both in-licensing and out-licensing strategies.
How our licensing & deal strategy service delivers value to your organization.
Machine learning-driven identification of licensing targets matching your therapeutic focus and strategic gaps.
Comprehensive asset valuation with probability-adjusted NPV, comparable deal analysis, and scenario modeling.
Term sheet development with milestone design, royalty structures, and territory rights optimization.
Expert negotiation support with data-driven justification for valuation and deal terms.
Comprehensive deliverables that provide actionable intelligence for your team.
A structured methodology that delivers results in four phases.
Identify portfolio gaps and strategic needs that licensing can address.
AI-powered screening of global assets matching your criteria with scoring and ranking.
Detailed valuation of priority targets with comparable deal analysis and scenario modeling.
Support term sheet development, negotiation, and deal closure.
We use AI to scan global pipelines, clinical trial registries, patent databases, and conference presentations to identify assets matching your therapeutic focus, development stage, and strategic criteria.
Yes, we support both strategies. For in-licensing, we identify acquisition targets. For out-licensing, we identify potential partners for your assets and support deal structuring.
We use comparable deal analysis, risk-adjusted NPV, probability of success by therapeutic area, and platform technology valuation methods for early-stage assets.
Commercial, technical, and regulatory due diligence for pharmaceutical and biotech acquisitions.
Learn moreData-driven asset valuation and portfolio optimization using clinical, commercial, and regulatory risk scoring.
Learn moreDetailed market sizing, forecasting, and competitor positioning to identify white space and launch opportunities.
Learn moreConnect with our team to discuss how our licensing & deal strategy service can support your goals.
Schedule a Consultation